Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Is AS Only Important When Severe?

Aortic stenosis (AS) is a progressive disease associated with morbidity and mortality, especially in severe cases. However, recent studies have revealed that moderate stenosis can also have unfavorable consequences in the course of the disease.

¿Solo es importante la estenosis aórtica severa?

One of the challenges lies in that determining its severity is sometimes difficult due to discrepancies between valve area, gradient, and peak velocity, which can lead to confusion regarding the presence of symptoms.

In a study that included 595,120 patients, 70,778 (11.9%) were identified as having some degree of AS. Of them, 48.9% had mild stenosis (L), 8.2% mild to moderate (L/M), 20.6% moderate (M), 5.2% moderate to severe (M/S), and 17.1% severe (S) stenosis.

As AS became more severe, there was an increase in age and risk factors such as hypertension, diabetes, atrial fibrillation, coronary artery disease, heart attack, percutaneous coronary intervention, myocardial revascularization surgery, chronic obstructive pulmonary disease, cancer, ejection fraction lower than 50%, smaller aortic valve area, lower gradient, and higher presence of atrioventricular valve regurgitation.

Read also: Low Gradient, Normal Flow Aortic Stenosis: Changes in Quality of Life with TAVR.

After four years of follow-up, mortality among those who did not receive treatment was 13.5% (95% CI: 13.3%-13.7%) for those without AS, and for those with mild, mild to moderate, moderate, moderate to severe, and severe AS it was 25.0%, 29.7%, 33.5%, 45.7%, and 44.9%, respectively. In those who received treatment, the mortality rate was 0.2%, 1.0%, 4.2%, 11.4%, 36.7%, and 60.7%, respectively.

In an adjusted multivariate analysis, untreated aortic stenosis, regardless of the degree, was associated with an increase in mortality.

Conclusion

In conclusion, patients with aortic stenosis face a significant risk of mortality at all severity levels without treatment. Nevertheless, aortic valve replacement remains low in cases of severe aortic stenosis, indicating the need for further research to understand diagnostic barriers and define the appropriate timing for aortic valve replacement.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: The Mortality Burden of Untreated Aortic Stenosis. 

Reference: Philippe Généreux, et al. J Am Coll Cardiol 2023;82:2101–2109. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...